NCT00506987View on ClinicalTrials.gov

Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887)

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Cough
Interventions
DRUG

SCH 486757

SCH 486757 2 x 50-mg capsule twice daily orally for 2 weeks followed by a 2-week washout period and 2 weeks of crossover treatment

DRUG

Placebo Dose 1

Matching placebo capsules twice daily orally for 2 weeks followed by a 2 week washout period and 2 weeks of crossover treatment

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00506987 - Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887) | Biotech Hunter | Biotech Hunter